Comparison between cefixime and co-amoxiclave therapeutic effects in outpatient treatment of acute community acquired pneumonia
Not Applicable
Completed
- Conditions
- Pneumonia.Pneumonia due to Haemophilus influenzae
- Registration Number
- IRCT201111186056N4
- Lead Sponsor
- Vice Chancellor for Research, Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 310
Inclusion Criteria
diagnosis of acute community acquired pneumonia; age more than15 years and capable of giving informed consent.
Exclusion criteria: immune deficiency disease or corticosteroids medication; allergy to beta-lactam drugs and weight less than 35 kg
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Therapeutic effects. Timepoint: At the begining, 2th and 4th weeks. Method of measurement: Clinical examination and chest X ray.
- Secondary Outcome Measures
Name Time Method Pulmonary abscess. Timepoint: Second and 4th weeks. Method of measurement: Clinical examination and chest X ray.;Pulmonary empyema. Timepoint: 2TH,4TH WEEKS. Method of measurement: clinical examination and CXR.;Pleural effusion. Timepoint: Second and 4th weeks. Method of measurement: Clinical examination and chest X ray.